Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 study evaluated the pharmacokinetics and pharmacodynamics of topiramate for weight loss in children with obesity. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Obesity

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: University of Minnesota | Conditions: Obesity, Childhood | EARLY_Phase 1 | Status: COMPLETED